v3.26.1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Preferred Stock
Common Stock
Predecessor Class A Common Stock
Common Stock
Predecessor Class B Common Stock
Common Stock
Successor Class A Common Stock
Common Stock
Successor Class B Common Stock
Additional Paid-in Capital
Retained Earnings/(Accumulated Deficit)
Balance at beginning of period (in shares) at Dec. 31, 2024   1,158,802            
Balance at beginning of period at Dec. 31, 2024 $ 23,342 $ 72,488 $ 0 $ 0     $ 0 $ (49,146)
Balance at beginning of period (in shares) at Dec. 31, 2024     2,000,000 400,970        
Stockholders' Equity                
Net loss (3,749)             (3,749)
Balance at end of period (in shares) at Mar. 31, 2025   1,158,802            
Balance at end of period at Mar. 31, 2025 $ 19,593 $ 72,488 $ 0 $ 0     0 (52,895)
Balance at end of period (in shares) at Mar. 31, 2025     2,000,000 400,970        
Balance at beginning of period (in shares) at Dec. 31, 2025 2,012,729              
Balance at beginning of period at Dec. 31, 2025 $ 148,802              
Mezzanine Equity                
Issuance of Variable Rate Series A Perpetual Preferred Stock (in shares) 2,360,465              
Issuance of Variable Rate Series A Perpetual Preferred Stock $ 219,905              
Issuance costs $ (9,533)              
Balance at end of period (in shares) at Mar. 31, 2026 4,373,194              
Balance at end of period at Mar. 31, 2026 $ 359,174              
Balance at beginning of period at Dec. 31, 2025 582,436       $ 699 $ 196 1,055,595 (474,054)
Balance at beginning of period (in shares) at Dec. 31, 2025         34,936,745 9,776,540    
Stockholders' Equity                
Adjustment of par value as a result of reverse stock split 0       $ (664) $ (186) 850  
Business combination with Semler Scientific Inc. (in shares)         16,090,786      
Business combination with Semler Scientific, Inc. 311,183       $ 16   311,167  
Share-based compensation expense 6,529           6,529  
Issuance of Class A common stock (in shares)         8,182,150      
Issuance of Class A common stock 94,953       $ 8   94,945  
Issuance of common stock upon vesting of restricted stock, net of withholding taxes (in shares)           118,950    
Issuance of common stock upon vesting of restricted stock, net of withholding taxes (388)           (388)  
Exercise of warrants (in shares)         53,614      
Conversions of Class B common stock to Class A common stock (in shares)         23,333 (23,333)    
Issuance costs (570)           (570)  
Dividends on preferred stock (13,454)             (13,454)
Net loss (265,906)             (265,906)
Balance at end of period at Mar. 31, 2026 $ 714,783       $ 59 $ 10 $ 1,468,128 $ (753,414)
Balance at end of period (in shares) at Mar. 31, 2026         59,286,628 9,872,157